IDDF2021-ABS-0204 SARS-COV-2 productively infects human liver and biliary organoids

Background SARS-CoV-2 has caused the COVID-19 pandemic, 14-53% with COVID-19 developed hepatic dysfunction. More data is required to ascertain the pattern of liver injury in patients with COVID-19. Here we report the use of human liver and biliary organoids as a tool to investigate the SARSCoV- 2 infection and virus-induced tissue damage ex vivo at the cellular and molecular levels. Methods Immunofluorescence staining and RT-qPCR was performed to examine the susceptibility and replication of human liver and biliary organoids to SARS-CoV-2. Transmission electron microscopy was performed to investigate the ultrastructure of SARS-CoV-2 infected biliary organoid. The mRNA sequence analysis was performed to determine gene expression changes induced by SARS-CoV-2-infection of biliary organoids. Results Immunofluorescence staining showed that SARS-CoV-2 spike (S) glycoprotein protein was readily detected in patchy areas of the human liver and biliary organoids, whereas no signal was found in uninfected control. RT-qPCR showed that the SARS-CoV-2 genomic RNAs revealed a dramatic increase of viral load in organoids at 24 h post-infection (MOI=1) and it can remain stable 96 hours in the liver organoids and 48 hours in biliary organoids. Unsupervised transmission electron microscopy (TEM) showed that viral particles occurred in the lumen of the organoid, at the basolateral and apical side of the organoid, even in membrane-bound vesicles. Additionally, RNA-seq revealed early cell response to virus infection, including the well-known upregulation of chemokines and inflammatory cytokines. Conclusions Therefore, the hepatocytes and bile duct cells have effectively been infected by COVID-19, and human liver and biliary organoids can serve as a pathophysiological model to investigate the underlying mechanism of SARS-CoV-2 infection.